THESEUS PHARMACEUTICALS, INC. Other Nonoperating Income
THESEUS PHARMACEUTICALS, INC. reported Other Nonoperating Income of $2.90 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. other nonoperating income for the quarter ending 2023-09-30 was $2.90M, a 140.98% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. other nonoperating income for the quarter ending 2023-06-30 was $2.78M, a 545.48% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. other nonoperating income for the quarter ending 2023-03-31 was $2.47M, a 2910.98% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. other nonoperating income for the quarter ending 2022-12-31 was $1.76M, a 58633.33% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. other nonoperating income for fiscal 2022 was $3.48M, a 12321.43% increase from fiscal 2021.
- THESEUS PHARMACEUTICALS, INC. other nonoperating income for fiscal 2021 was $28.00K.
| Period end | Other Nonoperating Income 3 month | Other Nonoperating Income 6 month | Other Nonoperating Income 9 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|
| 2023-09-30 | $2.90M 10-Q · filed 2023-11-17 | $5.68M derived: sum of 2 quarters · filed 2023-11-17 | $8.15M 10-Q · filed 2023-11-17 | $9.91M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $2.78M 10-Q · filed 2023-08-10 | $5.25M 10-Q · filed 2023-08-10 | $7.01M derived: sum of 3 quarters · filed 2023-08-10 | $8.22M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $2.47M 10-Q · filed 2023-05-11 | $4.23M derived: sum of 2 quarters · filed 2023-05-11 | $5.43M derived: sum of 3 quarters · filed 2023-11-17 | $5.87M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.96M derived: sum of 2 quarters · filed 2023-11-17 | $3.40M derived: sum of 3 quarters · filed 2023-11-17 | $3.48M 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.20M 10-Q · filed 2023-11-17 | $1.63M derived: sum of 2 quarters · filed 2023-11-17 | $1.72M 10-Q · filed 2023-11-17 | $1.72M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-06-30 | $431.00K 10-Q · filed 2023-08-10 | $513.00K 10-Q · filed 2023-08-10 | $516.00K derived: sum of 3 quarters · filed 2023-08-10 | $518.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $82.00K 10-Q · filed 2023-05-11 | $85.00K derived: sum of 2 quarters · filed 2023-05-11 | $87.00K derived: sum of 3 quarters · filed 2023-05-11 | $94.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $5.00K derived: sum of 2 quarters · filed 2023-03-09 | $12.00K derived: sum of 3 quarters · filed 2023-03-09 | $28.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-03 | $9.00K derived: sum of 2 quarters · filed 2022-11-03 | $25.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $7.00K 10-Q · filed 2022-08-11 | $23.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $16.00K 10-Q · filed 2022-05-12 |